Viewing Study NCT04026412

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-03-22 @ 9:27 AM
Study NCT ID: NCT04026412
Status: COMPLETED
Last Update Posted: 2025-07-24
First Post: 2019-07-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer (NSCLC) View
Keywords: